Pyrrolo [1,2-C] imidazole derivates for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies

Details for Australian Patent Application No. 2008319767 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Yamaoka, Masuo; Hara, Takahito

Agent Griffith Hack

Pub. Number AU-A-2008319767

PCT Pub. Number WO2009/057795

Priority 2007-280813 29.10.07 JP

Filing date 28 October 2008

Wipo publication date 7 May 2009

International Classifications

A61K 31/4188 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

17 June 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 27 May 2010

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/057795 Priority application(s): WO2009/057795

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008319808-Threaded joint for pipes having a lubricating coating

2008319749-Granulated powder of transition metal compound for raw material for positive electrode active material of lithium secondary battery, and method for producing the same